Abstract
We describe a rapid liquid chromatography/mass spectrometry (LC/MS) method for the direct detection and quantitation of SARS-CoV-2 nucleoprotein in gargle solutions and saliva. The method is based on a multiple-reaction monitoring (MRM) mass spectrometry approach with a total cycle time of 5 minutes per analysis and allows the detection and accurate quantitation of SARS-CoV-2 nucleoprotein as low as 500 amol/µl. We improved the sample preparation protocol of our recent piloting SARS-CoV-2 LC/MS study regarding sensitivity, reproducibility, and compatibility with a complementary reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) analysis of the same sample. The aim of this work is to promote diagnostic tools that allow identifying and monitoring SARS-CoV-2 infections by LC/MS methods in a routine clinical environment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Deutsche Forschungsgemeinschaft: RTG 2467, project number 391498659, Intrinsically Disordered Proteins: Molecular Principles, Cellular Functions, and Diseases, Region of Saxony-Anhalt, Martin Luther University Halle-Wittenberg, Center for Structural Mass Spectrometry
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The oversight body is the "Ethik-Kommission der Medizinischen Fakultaet der Martin-Luther-Universitaet Halle-Wittenberg". They consider our work as follows: Announcement of this work is sufficient at the safety officers at the Martin Luther University Halle-Wittenberg and the regional authority at Magdeburg, Germany.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data referred to in the manuscript are in the Supplementary Informaion.
Abbreviations
- ACN
- Acetonitrile
- ct
- Cycle time
- ESI
- Electrospray ionization
- FA
- Formic acid
- FASP
- Filter-aided sample preparation
- HPLC
- High-performance liquid chromatography
- LC
- Liquid chromatography
- LOD
- Limit of detection
- LOQ
- Limit of quantitation
- MRM
- Multiple-reaction monitoring
- MS
- Mass spectrometry
- MS/MS
- Tandem mass spectrometry
- RT-qPCR
- Reverse transcription quantitative polymerase chain reaction
- TFA
- Trifluoroacetic acid
- UPLC
- Ultra high-performance liquid chromatography